Pricing Update: Tariffs, and Changes to Product and Shipping Costs

As you may be aware, recent tariff changes have significantly increased the cost of international shipping to the United States. For our U.S. customers, shoes are the only products we manufacture in China and ship to the U.S., which means they are the ones directly affected. As a result, we have had to raise our shipping charges. To reduce the impact of these increased costs, we have temporarily lowered the product price of our shoes, resulting in a small overall reduction in the total price.

Shipping costs for shoes have also risen in other countries, though this is due to general increases in international freight rather than U.S. tariffs. To keep things consistent, we have reduced the product price of our shoes across all regions. This means that even with higher shipping charges, customers in every market are now paying slightly less overall compared to before the pricing change.

Below is an example of a customer ordering 1 pair of shoes and shipping them to the United States.

Why Are We Reducing Product Prices?

We’ve chosen to lower our shoe prices to ease the impact of higher shipping costs on our customers in the lead-up to Christmas. Shipping charges have had to increase, both to cover tariffs in the U.S. and due to rising international freight costs more generally. To balance this, we have reduced the price of all shoes. In some cases the overall reduction is only small, while in others it is more noticeable - but in every case, your total cost is now lower than before.

Looking Ahead

Please note that the reduced pricing is a short-term measure. We are monitoring developments closely, including the upcoming Supreme Court review of the tariff rules, with oral arguments scheduled to begin in early November. Once a decision has been handed down, we will reassess both product pricing and shipping charges.

Our aim is to manage these changes fairly and responsibly, keeping your overall costs as stable as possible while the tariff rules remain under review.